MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why LMRI Stock advanced +0.95% Today — RQD Quant Desk Flash
$11.73 +0.95% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $11.73
Lumexa Imaging Holdings Inc. (LMRI) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $1.13B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $11.73 (-0.02%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 0.8% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LMRI)Realized 20D OHLCV Swing Band: ±9.1%
Deterministic 5-Pillar Attribution (58/100 Composite)
🔍 WHY LMRI SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (22% of score)
FRED Regime × Technicals: 41% of 52W Range • RSI-14 at 57.4 (BULLISH MOMENTUM)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$10.54+2.3% Next Q
50
Q2 (-2Q)Grade C-$10.78+8.2% Next Q
53
Q3 (-1Q)Grade C$11.66+0.6% Next Q
55
CurrentGrade D+$11.73+0% Hist 90D α
58
Trajectory: C- (50) → D+ (58)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the LMRI Bull Thesis Could Fail
Even with a 58/100 (D+) score, LMRI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($11.11) or 200D SMA ($11.10) invalidates the momentum regime and cuts Target Base ($11.73) toward Bear Floor ($9.15).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $LMRI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LMRI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LMRI Stock advanced +0.95% Today — RQD Quant Desk Flash
Lumexa Imaging Holdings Inc. (LMRI) advanced +0.95% to $11.73, trading at 41% of its 52-week range ($6.45 – $19.45). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 41% of its 52-week range ($6.45 – $19.45) with RSI-14 at 57.4 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±9.1% around $11.73 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $31.6M annual free cash flow.
Live LMRI Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LMRI)
- ✓Walkthrough of LMRI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LMRI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +22.57%⚡ TESTING RESISTANCE
2026-10-30O $11.80H $11.88L $11.26C $11.73VOL 244.5K
RES: $11.96SUP: $9.82SMA50: $11.11SMA200: $11.10
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LMRI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LMRI today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LMRI. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LMRI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LMRI)
Health Care Rank #228 of 1016
⚔️ CSTL vs LMRI Full Matrix →
1. Head-to-Head Health Care Peer Comparison (LMRI vs. CSTL, TRUP, FRNM, ALHC)
Industry: Medical Specialities (41 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Lumexa Imaging Holdings Inc. (LMRI) ranks #228 by composite RQD confidence (58/100, grade D+) and #347 by equity capitalization ($1.13B). Within this direct 5-issuer industry benchmark cohort, TRUP leads on earnings valuation at 68.2x trailing P/E, while ALHC leads on capital efficiency and profitability with 13.9% ROIC and — gross margin. ALHC currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with LMRI at 58/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LMRI
ACTIVE
Lumexa Imaging Holdings Inc. | D+ | 58/100 | — | — | — | +0.95% | $1.13B | Benchmark Subject |
| CSTL Castle Biosciences Inc. | C- | 60/100 | — | 79.4% | -9.3% | +4.99% | $1.18B | /cstl-vs-lmri → |
| TRUP Trupanion Inc. | C | 64/100 | 68.2x | 16.1% | 3.1% | +2.27% | $1.32B | /trup-vs-lmri → |
| FRNM Freenome Inc. | E | 31/100 | — | — | -3.4% | -4.32% | $1.38B | /frnm-vs-lmri → |
| ALHC Alignment Healthcare Inc. | C+ | 67/100 | — | — | 13.9% | -1.47% | $1.67B | /alhc-vs-lmri → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002071288In its most recent audited fiscal period (FY2025, filed 2025-12-31), Lumexa Imaging Holdings Inc. (LMRI) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, LMRI closed FY2025 with $1.76B in total assets against $819.0M in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | $0 | — | — | $1.76B | $819.0M |
3. LMRI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs LMRI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Lumexa Imaging Holdings Inc. (NASDAQ: LMRI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $11.73 (+0.95% 1D, market cap $1.13B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, LMRI ranks #228 in composite RQD confidence.
How does LMRI compare to CSTL and TRUP in the Health Care sector?
Within the Health Care sector (Medical Specialities), LMRI carries a Roarable D+ (58/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CSTL (Castle Biosciences Inc.) holds a C- grade (60/100 RQD, P/E N/A, ROIC -9.3%, cap $1.18B) and TRUP (Trupanion Inc.) posts a C grade (64/100 RQD, P/E 68.2x, ROIC 3.1%, cap $1.32B). Among the 5-stock peer group, TRUP leads on earnings multiple (68.2x) while ALHC leads on capital efficiency (13.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for LMRI?
Per LMRI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002071288), Lumexa Imaging Holdings Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $1.76B in total assets and $819.0M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is LMRI trading relative to its 50-day, 200-day, and 52-week technical levels?
LMRI last traded at $11.73 (+0.95% on volume of 200,191 shares), positioning the stock +5.58% above its 50-day simple moving average ($11.11) and +5.68% above its 200-day simple moving average ($11.10). Across its 52-week range of $6.45 to $19.45, LMRI sits at the 40.6% percentile with a 14-day RSI of 57.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±9.1% ($10.66 to $12.80).
LMRI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LMRI stock moving today?
Why LMRI Stock advanced +0.95% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.